Cetera Investment Advisers’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468K Buy
43,658
+31,313
+254% +$242K ﹤0.01% 3765
2026
Q1
$78.6K Sell
12,345
-1,594
-11% -$11.1K ﹤0.01% 4512
2025
Q4
$98.1K Buy
13,939
+34
+0.2% +$205 ﹤0.01% 4401
2025
Q3
$76.5K Buy
+13,905
New +$68.1K ﹤0.01% 4372
2023
Q4
Sell
-18,745
Closed -$129K 2303
2023
Q3
$129K Buy
+18,745
New +$152K ﹤0.01% 2054

Other funds holding LFST

Cetera Investment Advisers's LFST Position: Q2 2026 in Review

Cetera Investment Advisers increased its Lifestance Health (LFST) stake by 254% in Q2 2026, buying an estimated $242K and bringing the position to 43,658 shares worth $468K. The position accounts for ﹤0.01% of the portfolio, ranked #3765.

Cetera Investment Advisers first reported a position in LFST in Q3 2023 and has held it in 5 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Cetera Investment Advisers held 43,658 shares of Lifestance Health worth $468K as of Q2 2026.
  • Cetera Investment Advisers bought 31,313 Lifestance Health shares in Q2 2026, an estimated $242K.
  • Lifestance Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3765 holding.
  • Cetera Investment Advisers first reported a position in Lifestance Health in Q3 2023 and has held it in 5 quarters since.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.